Cornerstone Wealth Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $493K | Sell |
20,478
-1,683
| -8% | -$44K | 0.03% | 244 |
|
|
2026
Q1 | $605K | Buy |
22,161
+1,670
| +8% | +$44.5K | 0.04% | 211 |
|
|
2025
Q4 | $510K | Buy |
20,491
+132
| +0.6% | +$3.33K | 0.03% | 203 |
|
|
2025
Q3 | $519K | Buy |
20,359
+2,480
| +14% | +$61.2K | 0.04% | 193 |
|
|
2025
Q2 | $433K | Buy |
17,879
+881
| +5% | +$20.5K | 0.03% | 199 |
|
|
2025
Q1 | $431K | Buy |
16,998
+268
| +2% | +$7.01K | 0.04% | 183 |
|
|
2024
Q4 | $444K | Sell |
16,730
-100
| -0.6% | -$2.71K | 0.04% | 174 |
|
|
2024
Q3 | $487K | Buy |
16,830
+299
| +2% | +$8.72K | 0.04% | 168 |
|
|
2024
Q2 | $463K | Buy |
16,531
+1,119
| +7% | +$30.8K | 0.04% | 166 |
|
|
2024
Q1 | $428K | Buy |
15,412
+6,452
| +72% | +$179K | 0.04% | 170 |
|
|
2023
Q4 | $258K | Buy |
8,960
+399
| +5% | +$12.1K | 0.04% | 130 |
|
|
2023
Q3 | $284K | Sell |
8,561
-686
| -7% | -$24.3K | 0.05% | 126 |
|
|
2023
Q2 | $339K | Sell |
9,247
-122,769
| -93% | -$4.78M | 0.06% | 120 |
|
|
2023
Q1 | $5.39M | Buy |
132,016
+3,536
| +3% | +$153K | 0.96% | 29 |
|
|
2022
Q4 | $6.58M | Buy |
128,480
+3,401
| +3% | +$163K | 1.25% | 20 |
|
|
2022
Q3 | $5.47M | Buy |
125,079
+116,125
| +1,297% | +$5.64M | 1.21% | 23 |
|
|
2022
Q2 | $469K | Sell |
8,954
-9
| -0.1% | -$459 | 0.1% | 98 |
|
|
2022
Q1 | $464K | Sell |
8,963
-2,664
| -23% | -$138K | 0.09% | 118 |
|
|
2021
Q4 | $687K | Buy |
11,627
+914
| +9% | +$45.3K | 0.12% | 107 |
|
|
2021
Q3 | $461K | Buy |
10,713
+580
| +6% | +$25.7K | 0.08% | 118 |
|
|
2021
Q2 | $407K | Sell |
10,133
-66
| -0.6% | -$2.57K | 0.08% | 119 |
|
|
2021
Q1 | $403K | Sell |
10,199
-65,423
| -87% | -$2.32M | 0.08% | 127 |
|
|
2020
Q4 | $2.78M | Sell |
75,622
-5,167
| -6% | -$190K | 0.68% | 52 |
|
|
2020
Q3 | $2.81M | Buy |
80,789
+72,180
| +838% | +$2.53M | 0.77% | 36 |
|
|
2020
Q2 | $267K | Sell |
8,609
-218
| -2% | -$7.41K | 0.07% | 106 |
|
|
2020
Q1 | $273K | Sell |
8,827
-339
| -4% | -$11.6K | 0.1% | 93 |
|
|
2019
Q4 | $341K | Buy |
9,166
+463
| +5% | +$16.5K | 0.09% | 117 |
|
|
2019
Q3 | $297K | Sell |
8,703
-39,446
| -82% | -$1.43M | 0.07% | 108 |
|
|
2019
Q2 | $1.98M | Sell |
48,149
-6,950
| -13% | -$276K | 0.53% | 47 |
|
|
2019
Q1 | $2.22M | Buy |
+55,099
| New | +$2.21M | 0.56% | 39 |
|
Other funds holding PFE
Cornerstone Wealth Group's PFE Position: Q2 2026 in Review
Cornerstone Wealth Group reduced its Pfizer (PFE) stake by 7.6% in Q2 2026, selling an estimated $44K and leaving 20,478 shares worth $493K. The position accounts for 0.03% of the portfolio, ranked #244.
Cornerstone Wealth Group first reported a position in PFE in Q1 2019 and has held it in 30 quarters since. The position peaked at $6.58M in Q4 2022. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Cornerstone Wealth Group held 20,478 shares of Pfizer worth $493K as of Q2 2026.
- Cornerstone Wealth Group sold 1,683 Pfizer shares in Q2 2026, an estimated $44K.
- Pfizer made up 0.03% of Cornerstone Wealth Group's portfolio in Q2 2026, its #244 holding.
- Cornerstone Wealth Group first reported a position in Pfizer in Q1 2019 and has held it in 30 quarters since.
- Cornerstone Wealth Group's Pfizer position peaked at $6.58M in Q4 2022.
- 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Cornerstone Wealth Group's 13F filing for Q2 2026, filed 27 Jul 2026.